WVE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WAVE Life Sciences Ltd

Watchlist Manager

Watchlist

Price: 3.955 USD 6.89% Market Closed

Market Cap: $760.9m

	WAVE Life Sciences Ltd NASDAQ:WVE	SG
C	Citius Oncology Inc NASDAQ:CTOR	US
T	Temple & Webster Group Ltd OTC:TPLWF	AU
	Made Tech Group PLC F:5UH	UK
M	Manulife Financial Corp XPHS:MFC	CA

Profitability Summary

WAVE Life Sciences Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-333%

Negative 3Y Average Operating Margin

-184%

Declining Operating Margin

-109% > -333%

Negative Net Margin

-310%

Negative 3Y Average Net Margin

-169%

Declining Net Margin

-99% > -310%

Negative Free Cash Flow Margin

-295%

Negative 3Y Average Free Cash Flow Margin

-187%

Declining Free Cash Flow Margin

-24% > -295%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-385%

Declining ROIC

-204% > -569%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.